James E. Levine's Net Worth
-$125 Thousand
Who is James E. Levine?
James E. Levine does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cidara Therapeutics, Inc., Cardiff Oncology, Inc., and VERENIUM CORP.
SEC CIK
James E. Levine's CIK is 0001463151
Past Insider Trading and Trends
2021 was James E. Levine's most active year for acquiring shares with 7 total transactions. James E. Levine's most active month to acquire stocks was the month of August. 2013 was James E. Levine's most active year for disposing of shares, totalling 11 transactions. James E. Levine's most active month to dispose stocks was the month of September. 2020 saw James E. Levine paying a total of $118,016.41 for 191,891 shares, this is the most they've acquired in one year. In 2013 James E. Levine cashed out on 464,490 shares for a total of $436,664.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cidara Therapeutics, Inc. (CDTX) Snapshot price: $0.6599
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
∞
| 50K |
$2.01 | $100,720.00 | 50K |
Nov 10
| |||
Form 4
| +67.77% | 25K |
—
|
—
| 61.89K |
Mar 19
| |||
Form 4/A
|
∞
| 30K |
$1.91 | $57,240.00 | 30K |
Sep 24
| |||
Form 4
| +3.36% | 6.89K |
$2.51 | $17,296.41 | 211.89K |
Jan 28
| |||
Form 4
| +17.14% | 30K |
$1.91 | $57,240.00 | 205K |
Sep 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cardiff Oncology, Inc. (CRDF) Snapshot price: $1.72
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +100.00% | 30K |
$1.56 | $46,710.00 | 60K |
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
∞
| 30K |
$6.47 | $194,000.00 | 30K |
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VERENIUM CORP No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -109.17K |
$4.00 | -$436,664.00 |
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
| +4.79% | 4.99K |
$3.65 | $18,228.10 | 109.17K |
May 15
| |||
Form 4
| +31.58% | 25K |
$3.18 | $79,500.00 | 104.17K |
Aug 25
| |||
Form 4
| +46.15% | 25K |
$1.69 | $42,250.00 | 79.17K |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4
| +1,200.34% | 50.01K |
$2.51 | $125,266.50 | 54.17K |
Aug 13 - Aug 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||